These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9413697

  • 1. A retained catheter for retrobulbar administration of interferon for age-related macular degeneration.
    Lincoff H, Kreissig I, Gelisken F, Stanga P.
    Dev Ophthalmol; 1997; 29():69-77. PubMed ID: 9413697
    [No Abstract] [Full Text] [Related]

  • 2. Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study.
    Kertes PJ, Britton WA, Leonard BC.
    Can J Ophthalmol; 1997 Apr; 32(3):185-8. PubMed ID: 9131284
    [No Abstract] [Full Text] [Related]

  • 3. Interferon alfa-2a in the treatment of exudative age-related macular degeneration.
    Lewis ML, Davis J, Chuang E.
    Graefes Arch Clin Exp Ophthalmol; 1993 Nov; 231(11):615-8. PubMed ID: 8258394
    [Abstract] [Full Text] [Related]

  • 4. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.
    Poliner LS, Tornambe PE, Michelson PE, Heitzmann JG.
    Ophthalmology; 1993 Sep; 100(9):1417-24. PubMed ID: 8371932
    [Abstract] [Full Text] [Related]

  • 5. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
    Arch Ophthalmol; 1997 Jul; 115(7):865-72. PubMed ID: 9230826
    [Abstract] [Full Text] [Related]

  • 6. Interferon alpha-2a in the treatment of exudative senile macular degeneration.
    Jaakkola A, Anttila PM, Immonen I.
    Acta Ophthalmol (Copenh); 1994 Oct; 72(5):545-9. PubMed ID: 7534027
    [Abstract] [Full Text] [Related]

  • 7. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation.
    Engler CB, Sander B, Koefoed P, Larsen M, Vinding T, Lund-Andersen H.
    Acta Ophthalmol (Copenh); 1993 Feb; 71(1):27-31. PubMed ID: 7682747
    [Abstract] [Full Text] [Related]

  • 8. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
    Kirkpatrick JN, Dick AD, Forrester JV.
    Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
    [Abstract] [Full Text] [Related]

  • 9. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.
    Gillies MC, Sarks JP, Beaumont PE, Hunyor AB, McKay D, Kearns M, McClusky PJ, Sarks SH.
    Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184
    [Abstract] [Full Text] [Related]

  • 10. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
    Thoelen A, Menozzi M, Huber C, Messmer E.
    Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of age-associated macular degeneration with interferon-alfa-2a].
    Thölen A, Kain H, Messmer E.
    Ophthalmologe; 1993 Jun; 90(3):279-82. PubMed ID: 8334332
    [Abstract] [Full Text] [Related]

  • 12. Interferon-associated retinopathy in a young, insulin-dependent diabetic patient.
    Willson RL, Ross RD, Willson LM, Cohen G, Redfield TL, Gitter KA.
    Retina; 2000 Jun; 20(4):413-5. PubMed ID: 10950429
    [No Abstract] [Full Text] [Related]

  • 13. The medical and surgical management of age-related macular degeneration.
    Joffe L.
    Int Ophthalmol Clin; 1996 Jun; 36(2):99-116. PubMed ID: 8950637
    [No Abstract] [Full Text] [Related]

  • 14. Adult vitelliform macular degeneration: a clinical spectrum.
    Greaves AH, Sarks JP, Sarks SH.
    Aust N Z J Ophthalmol; 1990 May; 18(2):171-8. PubMed ID: 2390244
    [Abstract] [Full Text] [Related]

  • 15. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [Abstract] [Full Text] [Related]

  • 16. Results 28 months following transpupillary thermotherapy for classic and occult choroidal neovascularization in patients with age-related macular degeneration.
    Newsom RS, McAlister JC, Saeed M, El-Ghonemy K, McHugh JD.
    Ophthalmic Surg Lasers Imaging; 2005 Oct; 36(2):94-102. PubMed ID: 15792308
    [Abstract] [Full Text] [Related]

  • 17. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES.
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [Abstract] [Full Text] [Related]

  • 18. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
    Voelker M, Gelisken F, Ziemssen F, Wachtlin J, Grisanti S.
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
    [Abstract] [Full Text] [Related]

  • 19. Clinical experience with the Ben-Sira teledioptric system for use in age-related macular degeneration.
    Mayer A.
    Ger J Ophthalmol; 1996 Jul; 5(4):229-32. PubMed ID: 8854107
    [Abstract] [Full Text] [Related]

  • 20. Age-related macular degeneration: from neovascular to atrophic.
    Roy M, Kuehl E.
    Ann Ophthalmol; 1989 Nov; 21(11):429-31. PubMed ID: 2482684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.